SCHEMBL8310325

SCHEMBL8310325

COc1cccc(C=C2SC(=S)NC2=O)c1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 3/20 1.00
NAT1 P18440 3/20 0.78
CA2 P00918 1/20 0.62
GSK3A P49840 1/20 0.61
MEN1 O00255 1/20 0.61
ALDH1A1 P00352 1/20 0.61
POLB P06746 1/20 0.61
GAA P10253 1/20 0.61
MAPT P10636 1/20 0.61
HPGD P15428 1/20 0.61
KMT2A Q03164 1/20 0.61
GSK3B P49841 1/20 0.61
CISD1 Q9NZ45 2/20 0.58
MAOB P27338 1/20 0.58
PDE3A Q14432 1/20 0.57
PIM1 P11309 2/20 0.56
MTOR P42345 1/20 0.55
CSNK2A2 P19784 1/20 0.54
CLK1 P49759 1/20 0.54
CSNK2B P67870 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8310322 1.00 PDE4B (1.00) PDE4BNAT1CA2GSK3AMEN1
SCHEMBL8309671 0.88 NAT1 (1.00) PDE4BNAT1CA2GSK3BCISD1
SCHEMBL8309670 0.88 NAT1 (1.00) PDE4BNAT1CA2GSK3BCISD1
SCHEMBL8180678 0.86 GSK3A (0.79) PDE4BNAT1GSK3AMEN1ALDH1A1
SCHEMBL8180676 0.86 GSK3A (0.79) PDE4BNAT1GSK3AMEN1ALDH1A1
SCHEMBL8193222 0.86 NAT1 (0.76) PDE4BNAT1CA2GSK3AMEN1
SCHEMBL13499562 0.86 NAT1 (0.76) PDE4BNAT1CA2GSK3BCISD1
SCHEMBL15347653 0.86 NAT1 (0.76) PDE4BNAT1CA2GSK3AMEN1
SCHEMBL8193225 0.86 NAT1 (0.76) PDE4BNAT1CA2GSK3AMEN1
SCHEMBL4801327 0.86 PDE4B (0.75) PDE4BNAT1CA2GSK3BCISD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US disclosed
US-5464856-A Arylmethylenyl derivatives of imidazolidinones useful as antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1995-11-07 US disclosed
US-5306822-A Mono-, di- or tri-methoxyphenylmethylene-2-thioxo-4-oxazolidinone as antihistamines WARNER-LAMBERT COMPANY (US) 1994-04-26 US disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed
US-5208250-A Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents WARNER-LAMBERT COMPANY (US) 1993-05-04 US disclosed
EP-0343643-A2 Arylmethylenyl derivatives of thiazolidnones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflamatory agents WARNER-LAMBERT COMPANY (US) 1989-11-29 EP disclosed